# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA5283957 | 20 | Activity | = | 70 | % | ALA5237148 | % | Homo sapiens | |||
2. | Celecoxib | Celecoxib | IC50 | = | 55.6 | uM | ALA5237145 | 4.25 | nM | Homo sapiens | ||
3. | ALA5283957 | 20 | IC50 | = | 7.66 | uM | ALA5237145 | 5.12 | nM | Homo sapiens | ||
4. | ALA443508 | 2c, ISC-4 | Activity | = | 77 | % | ALA4393783 | % | Homo sapiens | |||
5. | 1-Benzylisatin | 3a | IC50 | > | 100 | uM | ALA4708029 | nM | Homo sapiens | |||
6. | ALA4754311 | 3l; KS120 | IC50 | = | 3.9 | uM | ALA4708029 | 5.41 | nM | Homo sapiens | ||
7. | ALA4777582 | 3k; KS102 | IC50 | = | 3 | uM | ALA4708029 | 5.52 | nM | Homo sapiens | ||
8. | ALA4745360 | 3j; KS100 | IC50 | = | 3.7 | uM | ALA4708029 | 5.43 | nM | Homo sapiens | ||
9. | ALA4755837 | 3i; KS122 | IC50 | = | 3.7 | uM | ALA4708029 | 5.43 | nM | Homo sapiens | ||
10. | ALA4742685 | 3h; KS106 | IC50 | = | 5.7 | uM | ALA4708029 | 5.24 | nM | Homo sapiens | ||
11. | ALA4778505 | 3a; KS104 | IC50 | > | 100 | uM | ALA4708029 | nM | Homo sapiens | |||
12. | ALA4791929 | 7b | IC50 | = | 8.8 | uM | ALA4675224 | 5.06 | nM | Homo sapiens | ||
13. | ALA4791929 | 7b | Activity | 0 | ALA4675224 | Dose-dependent effect | Homo sapiens | |||||
14. | ALA4781382 | 7c | IC50 | = | 10.5 | uM | ALA4675224 | 4.98 | nM | Homo sapiens | ||
15. | ALA4781382 | 7c | Activity | 0 | ALA4675224 | Dose-dependent effect | Homo sapiens | |||||
16. | ALA1482145 | SID14742883 | IC50 | = | 9.2 | uM | ALA4675224 | 5.04 | nM | Homo sapiens | ||
17. | ALA1482145 | SID14742883 | Activity | 0 | ALA4675224 | Dose-dependent effect | Homo sapiens | |||||
18. | ALA4794604 | 7j | IC50 | = | 4.5 | uM | ALA4675224 | 5.35 | nM | Homo sapiens | ||
19. | ALA4794604 | 7j | Activity | 0 | ALA4675224 | Dose-dependent effect | Homo sapiens | |||||
20. | ALA4791929 | 7b | Activity | 0 | ALA4675222 | Tde | Homo sapiens |